Living Well: A Web-based Intervention to Improve Quality of Life in Rural and Urban Ovarian Cancer Survivors
美好生活:基于网络的干预措施,提高农村和城市卵巢癌幸存者的生活质量
基本信息
- 批准号:10547784
- 负责人:
- 金额:$ 60.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AgeAnimalsAnxietyAttentionBehavioralBiological ProcessCancer PatientCancer SurvivorCancer SurvivorshipCaringChronicClinicClinicalCognitiveCoping SkillsDataDevelopmentDiagnosisDiseaseDisease ProgressionDistressElementsFatigueGoalsGynecologic OncologyHealth BenefitHealth PromotionHomeIncidenceInternetInterventionLongterm Follow-upMalignant Female Reproductive System NeoplasmMalignant NeoplasmsMalignant neoplasm of ovaryMediatingMental DepressionMoodsOnline SystemsOutcomeOutcome MeasureParticipantPatientsPopulationPrognosisPublic HealthQuality of lifeRandomized, Controlled TrialsRecurrenceRelaxationReportingResearchRuralSiteSocial isolationStressSupport SystemSurvival RateSurvivorsSymptomsTargeted ResearchTestingTimeTravelTumor PromotionVideoconferencingWomanWorkacceptability and feasibilityactive controlcohortcopingdepressive symptomsdirect applicationefficacy evaluationevidence baseexperiencehealth related quality of lifeimplementation barriersimprovedin vitro Modelinnovationintervention effectmindfulnessmindfulness-based stress reductionnovelperceived stressphysical symptompoor sleepprimary outcomeprogramspsychosocialrural settingsecondary outcomeside effectskillsstress managementstress reductionsymposiumtherapy designtumor progressionurban residenceweb-based intervention
项目摘要
Abstract
Over the last two decades, we and others have documented the chronic and often debilitating experience
of ovarian cancer survivorship which may include poor health related quality of life (HRQOL), elevated
anxiety and depression, poor sleep, fatigue, multiple symptoms/side effects, existential concerns, and a
generally poor prognosis. Because of compromises to many aspects of HRQOL combined with low rates
of survival for the majority of these patients, development of innovative approaches for improving HRQOL
and potentially improving clinical outcomes is of paramount importance. This need is particularly true in
rural settings where women may have less access to clinic-based support systems. Despite the multiple
challenges experienced by ovarian cancer survivors, research targeting the potential efficacy of
psychosocial interventions in enhancing HRQOL has been extremely limited. Over the last several years
this research team has developed and piloted a web-based group conferencing intervention entitled
Living Well (Web-Enhanced Lessons for Living) targeting key concerns of ovarian cancer survivors and
developed with input from survivors. The overarching goal of the present submission is to examine the
efficacy of the Living Well intervention vs. a Health Promotion active control intervention in a randomized
controlled trial in 256 ovarian cancer survivors who have completed primary treatment and are less than
5-years post-diagnosis. We hypothesize that the Living Well Intervention will be efficacious in improving
HRQOL, decreasing perceived stress (primary outcomes) and in decreasing depressive mood, anxiety,
and fatigue (secondary outcomes). This application is highly innovative because it combines elements of
evidence-based psychosocial interventions in a novel way to target the needs of ovarian cancer survivors,
using a state-of-the-art web and video conferencing platform that allows wide dissemination, including to
rural survivors. This work is highly translational as it is a direct application of findings from mechanistic
stress-related research to testing an intervention to reduce stress in ovarian cancer survivors. The
significance of the application is that this intervention has the potential to overcome prior barriers to the
implementation of such psychosocial interventions and improve HRQOL, thus providing public health
benefits to an understudied and compromised cancer population with a high likelihood of recurrence.
抽象的
在过去的二十年里,我们和其他人记录了这种长期且常常令人衰弱的经历
卵巢癌存活率的影响,其中可能包括与健康相关的生活质量 (HRQOL) 较差、升高
焦虑和抑郁、睡眠不佳、疲劳、多种症状/副作用、存在问题以及
一般预后不良。由于 HRQOL 的许多方面都受到了影响,加上比率较低
大多数患者的生存,开发创新方法来改善HRQOL
潜在地改善临床结果至关重要。这种需求在以下情况尤其如此:
在农村地区,妇女获得诊所支持系统的机会可能较少。尽管有多个
卵巢癌幸存者经历的挑战,针对潜在功效的研究
提高 HRQOL 的心理社会干预极其有限。过去几年
该研究团队开发并试行了一种基于网络的小组会议干预措施,名为
Living Well(网络增强生活课程)针对卵巢癌幸存者的关键问题和
根据幸存者的意见制定。本次提交的总体目标是审查
随机对照试验中“健康生活”干预措施与“健康促进”主动控制干预措施的效果
对 256 名卵巢癌幸存者进行的对照试验,这些幸存者已完成初级治疗并且病情低于
诊断后 5 年。我们假设健康生活干预措施将有效改善
HRQOL,减少感知压力(主要结果)并减少抑郁情绪、焦虑、
和疲劳(次要结果)。该应用程序具有高度创新性,因为它结合了以下元素
以一种新颖的方式针对卵巢癌幸存者的需求进行基于证据的心理社会干预,
使用最先进的网络和视频会议平台进行广泛传播,包括
农村幸存者。这项工作具有高度转化性,因为它是机械论研究结果的直接应用
与压力相关的研究,旨在测试减轻卵巢癌幸存者压力的干预措施。这
该应用的意义在于,这种干预有可能克服先前的障碍
实施此类社会心理干预措施并改善 HRQOL,从而提供公共卫生
对研究不足且复发可能性高的癌症人群有好处。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN K LUTGENDORF其他文献
SUSAN K LUTGENDORF的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN K LUTGENDORF', 18)}}的其他基金
Living Well: A Web-based Intervention to Improve Quality of Life in Rural and Urban Ovarian Cancer Survivors
美好生活:基于网络的干预措施,提高农村和城市卵巢癌幸存者的生活质量
- 批准号:
10064618 - 财政年份:2020
- 资助金额:
$ 60.26万 - 项目类别:
Living Well: A Web-based Intervention to Improve Quality of Life in Rural and Urban Ovarian Cancer Survivors
美好生活:基于网络的干预措施,提高农村和城市卵巢癌幸存者的生活质量
- 批准号:
10329950 - 财政年份:2020
- 资助金额:
$ 60.26万 - 项目类别:
Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance
行为对卵巢癌进展的影响:化疗耐药的作用
- 批准号:
9029078 - 财政年份:2016
- 资助金额:
$ 60.26万 - 项目类别:
Development of a Web-Based Group Intervention to Support Ovarian Cancer Survivors
开发基于网络的团体干预来支持卵巢癌幸存者
- 批准号:
9047253 - 财政年份:2015
- 资助金额:
$ 60.26万 - 项目类别:
Mechanisms of Health and Disease at the Behavioral-Biomedical Interface
行为-生物医学界面的健康与疾病机制
- 批准号:
9569948 - 财政年份:2014
- 资助金额:
$ 60.26万 - 项目类别:
Mechanisms of Health and Disease at the Behavioral-Biomedical Interface
行为-生物医学界面的健康与疾病机制
- 批准号:
10176525 - 财政年份:2014
- 资助金额:
$ 60.26万 - 项目类别:
Mechanisms of Health and Disease at the Behavioral-Biomedical Interface
行为-生物医学界面的健康与疾病机制
- 批准号:
10425276 - 财政年份:2014
- 资助金额:
$ 60.26万 - 项目类别:
Mechanisms of Health and Disease at the Behavioral-Biomedical Interface
行为-生物医学界面的健康与疾病机制
- 批准号:
9063165 - 财政年份:2014
- 资助金额:
$ 60.26万 - 项目类别:
Mechanisms of Health and Disease at the Behavioral-Biomedical Interface
行为-生物医学界面的健康与疾病机制
- 批准号:
10619011 - 财政年份:2014
- 资助金额:
$ 60.26万 - 项目类别:
Mechanisms of Health and Disease at the Behavioral-Biomedical Interface
行为-生物医学界面的健康与疾病机制
- 批准号:
8607446 - 财政年份:2014
- 资助金额:
$ 60.26万 - 项目类别:
相似国自然基金
癫痫模型动物中本能恐惧反应异常的神经环路机制研究
- 批准号:31700921
- 批准年份:2017
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
DISC1转基因动物焦虑样行为变异的神经回路特征和调控机制
- 批准号:31671116
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
基于光遗传学方法建立小鼠焦虑模型的研究
- 批准号:81571352
- 批准年份:2015
- 资助金额:110.0 万元
- 项目类别:面上项目
特质与状态焦虑动物模型相关性及中药有效组分干预
- 批准号:81302887
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
社会亲密行为对动物焦虑抑郁的改善及相关神经机制研究
- 批准号:31101648
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
In vivo calcium imaging during appetitive learning in HIV Tat transgenic mice exposed to cannabis
暴露于大麻的 HIV Tat 转基因小鼠食欲学习过程中的体内钙成像
- 批准号:
10696442 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
与后代表观遗传衰老和神经发育相关的母体炎症
- 批准号:
10637981 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
Evaluating the Effects of Animal Therapy on Anxiety in Pediatric Dental Patients
评估动物疗法对小儿牙科患者焦虑的影响
- 批准号:
10649010 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
Amnion cell secretome mediated therapy for traumatic brain injury
羊膜细胞分泌组介导的创伤性脑损伤治疗
- 批准号:
10746655 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
- 批准号:
10588414 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别: